Halda Therapeutics Email Format
Biotechnology ResearchConnecticut, United States11-50 Employees
Halda Therapeutics is a biotechnology company based in New Haven, Connecticut, dedicated to developing precision oncology medicines. Its core focus is RIPTAC therapeutics, a novel cancer treatment modality that works by bringing two proteins into close proximity, thereby disabling an essential function and triggering cancer cell death. The approach is designed to overcome common drug resistance by not depending on traditional oncogenic drivers, and the company is building a pipeline for major cancer types, with a lead program in prostate cancer. Founded by Yale professor Craig Crews, Halda operates from its headquarters and laboratories in Science Park, New Haven. With a small, focused team, the company is actively expanding its RIPTAC program slate for major solid tumors and recently announced a partnership with Proximabio.